Fed Chair Powell’s Recent Comments

New Report will be Ready to Release Tomorrow at Market Open. A Biopharma Company Working in a Big Market Sector with Novel Technology, Extremely Small Float, Trading Under $1/Share. More on this one below.

Good day everyone,

Federal Reserve Chairman Jerome Powell said Tuesday, at a Wall Street Journal event, that the central bank will continue to raise short-term interest rates to curb inflation. The Fed’s preferred measure of inflation showed prices rising by 6.6% on a yearly basis in March.

Mr. Powell said, “there could be some pain involved in restoring price stability, but we think we can sustain a strong labor market,”. The unemployment rate was at a historically low 3.6% in April. The Fed moved in March of this year to raise rates by 0.25% and in May, the Fed raised rates by 0.50%. Powell also said Tuesday that there was “broad support” for additional 0.50% moves in the next two policy-setting meetings.

Should both those rate increases happen, it would lift the federal funds rate somewhere between 1.75% and 2.00% by the end of July. “Sometimes the landing is just perfect, sometimes it’s just a little bumpy. It’s still a good landing, you don’t even notice it,” Powell said. The Fed’s next policy-setting meeting will take place June 14 and 15.

We want to discuss a NASDAQ biopharma company that is new to our members and working in one of the hottest biopharma sectors with a CAGR over 15%. This company started generating revenues late last year with a commercialized product that has a global market reach.

The chart setup indicates shares that are starting to trend off a double bottom, so the timing looks absolutely perfect. This company has a tiny share structure and a price/book ratio that is quite appealing. Like many biopharma companies listed on the NASDAQ, this one has had their market value crushed in 2022. I think as you read our report and see what this company has going on you will be surprised (I was) at how low their market cap is.

Stay tuned and stay informed. We will issue this report on Thursday, May 19, 2022, at or near the market open.

The Traders News Group

 

#Biotech, #Stockstobuy